Galectin Therapeutics Inc. | |
Stock Exchange | Frankfurt Stock Exchange |
EPS |
- |
Market Cap |
- |
Shares Outstanding |
37.74 M |
Public Float |
31.89 M |
Galectin Therapeutics Inc. | |
Stock Exchange | NASDAQ Stock Market |
EPS |
$0.32 |
Market Cap |
$221.76 M |
Shares Outstanding |
56 M |
Public Float |
34.4 M |
Address |
4960 Peachtree Industrial Boulevard Norcross Georgia 30071 United States |
Employees | - |
Website | http://www.galectintherapeutics.com |
Updated | 07/08/2019 |
Galectin Therapeutics, Inc. is a biotechnology company, which engages in drug research and development to create new therapies for fibrotic disease, severe skin disease, and cancer. Its programs targets the development of carbohdrate molecules which offers offer alternative options to larger market segments. The company was founded by James C. |